Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.10.0.1
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Income Statement [Abstract]        
Revenue
Operating expenses:        
Research and development, net of reimbursements 3,325,228 4,448,198 7,788,197 9,021,700
General and administrative 1,574,776 2,740,767 3,453,522 5,951,933
Depreciation expense 12,816 14,335 24,780 35,255
Total operating expenses 4,912,820 7,203,300 11,266,499 15,008,888
Loss from operations (4,912,820) (7,203,300) (11,266,499) (15,008,888)
Other income (expense):        
Interest income 50,030 80,372
Gain (loss) on change in fair value of derivative liabilities 149,592 (106,403)
Total other income (expense) 50,030 149,592 80,372 (106,403)
Net loss $ (4,862,790) $ (7,053,708) $ (11,186,127) $ (15,115,291)
Net loss per common share - basic and diluted $ (0.04) $ (0.12) $ (0.11) $ (0.26)
Weighted average common shares outstanding - basic and diluted 110,363,370 58,184,534 99,459,614 57,045,036